These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11250041)

  • 1. Characterization of HLA class I specific antibodies by ELISA using solubilized antigen targets: II. Clinical relevance.
    Zachary AA; Ratner LE; Graziani JA; Lucas DP; Delaney NL; Leffell MS
    Hum Immunol; 2001 Mar; 62(3):236-46. PubMed ID: 11250041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A limited number of HLA epitopes are recognized from HLA class I-specific antibodies detected in the serum of sensitized patients.
    Papassavas AC; Iniotaki-Theodoraki A; Boletis J; Douramani P; Kostakis A; Stavropoulos-Giokas C
    Hum Immunol; 2000 Jul; 61(7):705-10. PubMed ID: 10880741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of HLA class I specific antibodies by ELISA using solubilized antigen targets: I. Evaluation of the GTI QuikID assay and analysis of antibody patterns.
    Zachary AA; Delaney NL; Lucas DP; Leffell MS
    Hum Immunol; 2001 Mar; 62(3):228-35. PubMed ID: 11250040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HLA-DR phenotype of the responder is predictive of humoral response against HLA class I antigens.
    Dankers MK; Roelen DL; Nagelkerke NJ; de Lange P; Persijn GG; Doxiadis II; Claas FH
    Hum Immunol; 2004 Jan; 65(1):13-9. PubMed ID: 14700591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicity. Results of a blinded, controlled multicenter study.
    Buelow R; Mercier I; Glanville L; Regan J; Ellingson L; Janda G; Claas F; Colombe B; Gelder F; Grosse-Wilde H
    Hum Immunol; 1995 Sep; 44(1):1-11. PubMed ID: 8522449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus.
    El-Awar NR; Akaza T; Terasaki PI; Nguyen A
    Transplantation; 2007 Aug; 84(4):532-40. PubMed ID: 17713439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an antibody specific for HLA-A36 and not reactive with HLA-A1.
    Sikorski P; Kopchaliiska D; Lucas DP; Leffell MS; Zachary AA
    Hum Immunol; 2011 Jan; 72(1):87-90. PubMed ID: 20971147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and specification of noncomplement binding anti-HLA alloantibodies.
    Arnold ML; Zacher T; Dechant M; Kalden JR; Doxiadis II; Spriewald BM
    Hum Immunol; 2004 Nov; 65(11):1288-96. PubMed ID: 15556679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assignment of HLA-antigens in CREGs facilitates the detection of acceptable mismatches in highly sensitized patients.
    Papassavas AC; Iniotaki-Theodoraki A; Boletis J; Kostakis A; Stavropoulos-Giokas C
    Hum Immunol; 1998 Sep; 59(9):587-96. PubMed ID: 9757915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Bw4 and Bw6 epitope mismatches on antibody production, acute and chronic rejection, and graft survival in renal allografts.
    Leffell MS; Kraus E; Racusen LC; Ratner LE; Charney D; Zachary AA
    Transplantation; 2001 Aug; 72(3):433-7. PubMed ID: 11502972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance.
    Smith JD; Hornick PI; Rasmi N; Rose ML; Yacoub MH
    Ann Thorac Surg; 1998 Dec; 66(6 Suppl):S212-5. PubMed ID: 9930450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens.
    El-Awar N; Lee JH; Tarsitani C; Terasaki PI
    Hum Immunol; 2007 Mar; 68(3):170-80. PubMed ID: 17349872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of recipient antibodies to stem cell donor mismatched class I HLA antigens.
    Pollack MS; Ririe D
    Hum Immunol; 2004 Mar; 65(3):245-7. PubMed ID: 15041163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
    Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
    Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of donor-specific anti-human leukocyte antigen antibodies after the transplantation of a fully matched kidney allograft and its impact on the selection of a subsequent renal regraft: a case report.
    Schlaf G; Radam C; Wahle A; Altermann WW
    Transplant Proc; 2012 Jun; 44(5):1442-5. PubMed ID: 22664032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superiority of AbCross enzyme-linked immunosorbent assay cross-match over the B-cell complement-dependent lymphocytotoxicity cross-match.
    Gombos P; Opelz G; Scherer S; Morath C; Zeier M; Schemmer P; Langer RM; Süsal C
    Transplant Proc; 2013 May; 45(4):1383-5. PubMed ID: 23726578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques.
    Piazza A; Poggi E; Borrelli L; Servetti S; Monaco PI; Buonomo O; Valeri M; Torlone N; Adorno D; Casciani CU
    Transplantation; 2001 Apr; 71(8):1106-12. PubMed ID: 11374411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.
    Schönemann C; Groth J; Leverenz S; May G
    Transplantation; 1998 Jun; 65(11):1519-23. PubMed ID: 9645818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.